Correction: Reevaluation of Clinical Trials Involving Selective RET Inhibitors
Overview
This correction addresses the affiliation error for author Pengyu Wang in the review of selective RET inhibitors for thyroid cancer treatment. The updated affiliation is now listed as 'Independent Researcher, Xianning, China.' This correction is essential for maintaining the integrity of the authorship in the scientific literature.
Background
Accurate attribution of authorship and affiliations is crucial in scientific literature. Selective RET inhibitors have been studied in clinical trials for thyroid cancer, necessitating precise reporting.
Data Highlights
This correction article does not present numerical or trial data.
Key Findings
The affiliation for author Pengyu Wang was incorrectly listed and has now been corrected.
The updated affiliation for Pengyu Wang is 'Independent Researcher, Xianning, China.'
This correction is necessary for accurate author representation in clinical research.
Clinical Implications
Accurate author affiliations are essential for the credibility of clinical research.
Conclusion
This correction emphasizes the importance of maintaining accurate author information in scientific publications.
